 |
|
|
|
|
|
Previous 25 Showing Treatment 26 to 50 of 95 Next 25 |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase II Trial of Chemotherapy with Temozolomide in Combination with Topotecan for Central Nervous System (CNS) Metastases of Solid Tumors |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
|
|
Details |
|
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
Details |
|
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
|
|
Details |
|
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
Details |
|
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
|
|
Details |
|
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
Details |
|
Meningioma: Risk Factors and Quality of Life |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
|
|
Details |
|
Evaluating the Feasibility of Real-Time, Magnetic Resonance Thermal Imaging and Magnetic Resonance Imaging (MRI)-Guided Laser Induced Thermal Therapy (LITT) for the Treatment of Metastatic Brain Tumors |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
Details |
|
Molecular Biology of Central Nervous System (CNS) Tumors |
|
Houston, TX USA |
|
12/20/2010 |
|
|
|
|
|
Details |
|
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status (CORE) |
|
Dallas, TX USA |
|
11/12/2010 |
|
|
|
Details |
|
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Dallas, TX USA |
|
11/12/2010 |
|
|
|
|
|
Details |
|
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
San Antonio, TX USA |
|
11/12/2010 |
|
|
|
Details |
|
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Houston, TX USA |
|
11/12/2010 |
|
|
|
|
|
Details |
|
Phase I/II Trial of BIBW 2992 in Treating Patients With Recurrent Glioblastoma Multiforme
|
|
Dallas, TX USA |
|
11/12/2010 |
|
|
|
Details |
|
Cilengitide for Subjects With Newly Diagnosed Glioblastoma Multiforme and Methylated MGMT Gene Promoter - A Multicenter, Open-Label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide Maintenance Therapy) Versus Standard Treatment Alone |
|
Dallas, TX USA |
|
11/12/2010 |
|
|
|
|
|
Details |
|
RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Houston, TX USA |
|
04/13/2010 |
|
|
|
Details |
|
RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Galveston, TX USA |
|
04/13/2010 |
|
|
|
|
|
Details |
|
RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
San Antonio, TX USA |
|
04/13/2010 |
|
|
|
Details |
|
RTOG0627 Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Lubbock, TX USA |
|
04/13/2010 |
|
|
|
|
|
Details |
|
2009-0476: A Phase I dose-finding study of XL184 administered orally in combination with Temozolomide and Radiation Therapy in first line treatment of glioblastoma |
|
Houston, TX USA |
|
03/30/2010 |
|
|
|
Details |
|
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX USA |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2009-0548: A Phase I Study of MK-0752, a Notch Inhibitor, in Patients With recurrent glioma |
|
Houston, TX USA |
|
03/30/2010 |
|
|
|
Details |
|
2009-0597: Randomized Phase II Trial of Standard Dose Bevacizumab Versus Low Dose Bevacizumab plus Lomustine (CCNU) In Adults with Recurrent Glioblastoma Multiforme |
|
Houston, TX USA |
|
03/30/2010 |
|
|
|
|
|
Details |
|
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
|
Houston, TX USA |
|
03/30/2010 |
|
|
|
Details |
|
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
|
Houston, TX USA |
|
03/29/2010 |
|
|
|
|
|
